{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:07:53Z","timestamp":1761718073630,"version":"build-2065373602"},"reference-count":25,"publisher":"BMJ","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Genet"],"published-print":{"date-parts":[[1998,8]]},"abstract":"<jats:p>BACKGROUND: The potential of hyperechogenic fetal bowel to act as a hallmark for prenatal cystic fibrosis screening in the general population is controversial. METHODS: Our goal was to evaluate the incidence of cystic fibrosis in 209 fetuses with hyperechogenic bowel diagnosed at routine ultrasonography and with no family history of cystic fibrosis. The diagnosis of cystic fibrosis was based on prenatal screening for the eight mutations most frequently observed in France (deltaF508, deltaI507, 1717-1G--&gt;A, G542X, G551D, R553X, W1282X, N1303K) and at postnatal follow up. RESULTS: The overall incidence of cystic fibrosis was 7\/209 (3.3%) which is 84 times the estimated risk of CF in the general population (112500). Of these seven cases, six were diagnosed prenatally based on DNA analysis (deltaF508\/deltaF508, n=5; deltaF508\/G542X, n=1). One case in which only one mutation had been recognised was diagnosed clinically after birth (deltaF508\/unidentified mutation). Of the seven cases, none was diagnosed at 16-19 weeks, four at 16-24 weeks, and three after this. The incidence of heterozygous fetuses (15\/209, 7%) was not significantly higher than the 5% expected in the general population. The mutations involved in these heterozygous cases were deltaF508 (n=13), G542X (n=1), and G551D (n=1). CONCLUSIONS: Screening for cystic fibrosis should be offered to families in which fetal hyperechogenic bowel is diagnosed at routine ultrasonography. This underlines the need to review genetic counselling in this situation where the fetus is the index case for a genetic disease.<\/jats:p>","DOI":"10.1136\/jmg.35.8.657","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T15:37:21Z","timestamp":1226331441000},"page":"657-660","source":"Crossref","is-referenced-by-count":31,"title":["Cystic fibrosis screening: a fetus with hyperechogenic bowel may be the index case."],"prefix":"10.1136","volume":"35","author":[{"given":"F","family":"Muller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Dommergues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Simon-Bouy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Ferec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J F","family":"Oury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M C","family":"Aubry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Bessis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Vuillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Denamur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Bienvenu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J L","family":"Serre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1998,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.7863\/jum.1986.5.9.489","article-title":"Increased echogenicity in the lower fetal abdomen: a common normal variant in the second trimester","volume":"5","author":"Fakhry, J.; Reiser, M.; Shapiro, L.R.; Schechter, A.; Pait, L.P.; Glennon, A.","year":"1986","unstructured":"Fakhry J, Reiser M, Shapiro LR, Schechter A, Pait LP, Glennon A. Increased echogenicity in the lower fetal abdomen: a common normal variant in the second trimester. J Ultrasound Med 1986;5:489-92.","journal-title":"J Ultrasound Med"},{"key":"ref_2","first-page":"404","article-title":"Fetal small bowel simulating an abdominal mass at sonography","volume":"14","author":"Manco, L.G.; Nunan, F.A.; Sohnen, H.; Jacobs, E.J.","year":"1986","unstructured":"Manco LG, Nunan FA, Sohnen H, Jacobs EJ. Fetal small bowel simulating an abdominal mass at sonography. J Clin Ultrasound 1986;14:404-7. rate (6\/7). None of the children with no CFTR mutations identified prenatally developed clinical symptoms of CF postnatally. However, we are aware that the generalisation of our","journal-title":"J Clin Ultrasound; rate (6\/7). None of the children with no CFTR mutations identified prenatally developed clinical symptoms of CF postnatally"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7863\/jum.1991.10.4.211","article-title":"Sonography of normal fetal bowel","volume":"10","author":"Parulekar, S.G.","year":"1991","unstructured":"Parulekar SG. Sonography of normal fetal bowel. J Ultrasound Med 1991;10:210-11.","journal-title":"J Ultrasound Med"},{"key":"ref_4","first-page":"647","article-title":"Is fetal hyperechoic bowel on secondtrimester sonogram an indication for amniocentesis?","volume":"83","author":"Bromley, B.; Doubilet, P.; Frigoletto, F.; Krauss, C.; Estroff, J.; Benaceraf, B.","year":"1994","unstructured":"Bromley B, Doubilet P, Frigoletto F, Krauss C, Estroff J, Benaceraf B. Is fetal hyperechoic bowel on secondtrimester sonogram an indication for amniocentesis? Obstet Gynecol 1994;83:647-5 1. results should take into account the incidence of CF in the population screened and the vari-","journal-title":"Obstet Gynecol; 1. results should take into account the incidence of CF in the population screened and the vari"},{"key":"ref_5","first-page":"724","article-title":"Bowel abnormalities in the fetus - correlation of prenatal ultrasonographic findings with outcome","volume":"175","author":"Corteville, J.E.; Gray, D.L.; Langer, J.C.","year":"1996","unstructured":"Corteville JE, Gray DL, Langer JC. Bowel abnormalities in the fetus - correlation of prenatal ultrasonographic findings with outcome. Am J Obstet Gynecol 1996;175:724-9. ation in CF mutations according to ethnic background.","journal-title":"Am J Obstet Gynecol; ation in CF mutations according to ethnic background"},{"key":"ref_6","first-page":"350","article-title":"Prenatal sonographic findings of meconium peritonitis with pathologic correlation","volume":"10","author":"Blumenthal, D.H.; Rushovich, A.M.; Williams, R.K.; Rochester, D.","year":"1982","unstructured":"Blumenthal DH, Rushovich AM, Williams RK, Rochester D. Prenatal sonographic findings of meconium peritonitis with pathologic correlation. J Clin Ultrasound 1982;10:350-2. The major drawback of CF screening in fetuses with hyperechogenic bowel is in generating parental anxiety, especially when the fetus is found to be heterozygous for a CFTR mutation. In this situation, it is difficult to evaluate accurately the risk of misdiagnosing a rare","journal-title":"J Clin Ultrasound; The major drawback of CF screening in fetuses with hyperechogenic bowel is in generating parental anxiety, especially when the fetus is found to be heterozygous for a CFTR mutation. In this situation, it is difficult to evaluate accurately the risk of misdiagnosing a rare"},{"key":"ref_7","first-page":"683","article-title":"The clinical significance of increased echogenicity in the fetal abdomen","volume":"145","author":"Lince, D.M.; Pretorius, D.H.; Manco-Johnson, M.L.; Manchester, D.; Clewell, W.H.","year":"1985","unstructured":"Lince DM, Pretorius DH, Manco-Johnson ML, Manchester D, Clewell WH. The clinical significance of increased echogenicity in the fetal abdomen. AJ'R 1985;145:683-6.","journal-title":"AJ'R"},{"key":"ref_8","first-page":"370","article-title":"Prenatal sonographic findings of Down syndrome: review of 94","volume":"76","author":"Nyberg, D.A.; Resta, R.G.; Luthy, D.A.; Hickok, D.E.; Mahony, B.S.; Hirsch, J.H.","year":"1990","unstructured":"Nyberg DA, Resta RG, Luthy DA, Hickok DE, Mahony BS, Hirsch JH. Prenatal sonographic findings of Down syndrome: review of 94. Obstet Gynecol 1990;76:370-7.","journal-title":"Obstet Gynecol"},{"key":"ref_9","article-title":"Fetal abdominal echogenic mass: an early sign of intrauterine cytomegalovirus infection. Obstet Gynecol 1992; 80: 535-7. mutation in the other apparently normal chromosome. The number of mutations screened for is an intrinsic limitation of this approach to prenatal genetic screening","volume-title":"Increasing the","author":"Forouzan, I.","unstructured":"Forouzan I. Fetal abdominal echogenic mass: an early sign of intrauterine cytomegalovirus infection. Obstet Gynecol 1992; 80:535-7. mutation in the other apparently normal chromosome. The number of mutations screened for is an intrinsic limitation of this approach to prenatal genetic screening. Increasing the"},{"key":"ref_10","first-page":"508","article-title":"Hyperechogenic fetal bowel: an ultrasonographic marker for adverse fetal and neonatal outcome. Am3'","volume-title":"Obstet Gynecol","volume":"173","author":"Muller, F.; Dommergues, M.; Aubry, M.C.","year":"1995","unstructured":"Muller F, Dommergues M, Aubry MC, et al. Hyperechogenic fetal bowel: an ultrasonographic marker for adverse fetal and neonatal outcome. Am3' Obstet Gynecol 1995;173: 508-13."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/fn.74.1.F1","article-title":"Hyperechogenic fetal bowel","volume":"74","author":"Stringer, M.D.; Thornton, J.G.; Mason, G.C.","year":"1996","unstructured":"Stringer MD, Thornton JG, Mason GC. Hyperechogenic fetal bowel. Arch Dis Child 1996;74:F1-2.","journal-title":"Arch Dis Child"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(96)90210-X","article-title":"Prognostic implications of fetal echogenic bowel","volume":"347","author":"Slotnick, R.N.; Abuhamad, A.","year":"1996","unstructured":"Slotnick RN, Abuhamad A. Prognostic implications of fetal echogenic bowel. Lancet 1996;347:85-7.","journal-title":"Lancet"},{"key":"ref_13","first-page":"223","article-title":"Meconium ileus in cystic fibrosis fetuses","volume":"ii:","author":"Muller, F.; Frot, J.C.; Aubry, M.C.; Boue, J.; Boue, A.","year":"1984","unstructured":"Muller F, Frot JC, Aubry MC, Boue J, Boue A. Meconium ileus in cystic fibrosis fetuses. Lancet 1984;ii:223.","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/pd.1970141014","article-title":"Hyperechoic fetal bowel: the perinatal consequences","volume":"14","author":"Bahado-Singh, R.; Morotti, R.; Copel, J.A.; Mahoney, M.J.","year":"1994","unstructured":"Bahado-Singh R, Morotti R, Copel JA, Mahoney MJ. Hyperechoic fetal bowel: the perinatal consequences. Prenat Diagn 1994;14:981-7.","journal-title":"Prenat Diagn"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/pd.1970140913","article-title":"Second-trimester echogenic small bowel: an increased risk for adverse perinatal outcome","volume":"14","author":"Hill, L.M.; Fries, J.; Hecker, J.; Grzybek, P.","year":"1994","unstructured":"Hill LM, Fries J, Hecker J, Grzybek P. Second-trimester echogenic small bowel: an increased risk for adverse perinatal outcome. Prenat Diagn 1994;14:845-50.","journal-title":"Prenat Diagn"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/0002-9378(95)91365-3","article-title":"Isolated hyperechoic fetal bowel: significance and implications for management","volume":"173","author":"MacGregor, S.N.; Tamura, R.; Sabbagha, R.; Kambich, Brenhofer J.; MP, Pergament; E.","year":"1995","unstructured":"MacGregor SN, Tamura R, Sabbagha R, Brenhofer J Kambich MP, Pergament E. Isolated hyperechoic fetal bowel: significance and implications for management. Am Jf Obstet Gynecol 1995;173:1254-8.","journal-title":"Am Jf Obstet Gynecol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02428300","article-title":"The cystic fibrosis delta F508 mutation in the French population","volume":"85","author":"Simon-Bouy, B.; Mornet, E.; Serre, J.L.; Taillandier, A.; Boue, J.; Boue, A.","year":"1990","unstructured":"Simon-Bouy B, Mornet E, Serre JL, Taillandier A, Boue J, Boue A. The cystic fibrosis delta F508 mutation in the French population. Hum Genet 1990;85:431-2.","journal-title":"Hum Genet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0002-9378(97)70483-6","article-title":"Prenatal screening for cystic fibrosis: an updated perspective","volume":"176","author":"Doherty, R.A.; Bradley, L.A.; Haddow, J.E.","year":"1996","unstructured":"Doherty RA, Bradley LA, Haddow JE. Prenatal screening for cystic fibrosis: an updated perspective. Am Obstet Gynecol 1996;176:268-70.","journal-title":"Am Obstet Gynecol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/ng0692-188","article-title":"Detection of over 98% cystic fibrosis mutations in a Celtic population","volume":"1","author":"Ferec, C.; Audrezat, M.P.; Mercier, B.","year":"1992","unstructured":"Ferec C, Audrezat MP, Mercier B, et al. Detection of over 98% cystic fibrosis mutations in a Celtic population. Nat Genet 1992;1:188-91.","journal-title":"Nat Genet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9378(12)90875-3","article-title":"Reporting the results of cystic fibrosis carrier screening","volume":"168","author":"Asch, D.A.; Patton, J.P.; Hershey, J.C.; Mennuti, M.T.","year":"1993","unstructured":"Asch DA, Patton JP, Hershey JC, Mennuti MT. Reporting the results of cystic fibrosis carrier screening. Am Obstet Gynecol 1993;168:1-6.","journal-title":"Am Obstet Gynecol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0140-6736(93)91456-V","article-title":"First-trimester fetal screening of cystic fibrosis in low risk population","volume":"342","author":"Brambati, B.; Tului, L.; Fattore, S.; Ferec, C.","year":"1993","unstructured":"Brambati B, Tului L, Fattore S, Ferec C. First-trimester fetal screening of cystic fibrosis in low risk population. Lancet 1993;342:624.","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/bmj.308.6942.1459","article-title":"Antenatal screening for cystic fibrosis: a trial of the couple model","volume":"8","author":"Livingstone, J.; Axton, R.A.; Gilfillan, A.","year":"1994","unstructured":"Livingstone J, Axton RA, Gilfillan A, et al. Antenatal screening for cystic fibrosis: a trial of the couple model. BMJ 1994;8: 1459-62.","journal-title":"BMJ"},{"key":"ref_23","first-page":"903","article-title":"The costeffectiveness of prenatal carrier screening for cystic fibrosis","volume":"84","author":"Lieu, T.A.; Watson, S.E.; Washington, A.E.","year":"1994","unstructured":"Lieu TA, Watson SE, Washington AE. The costeffectiveness of prenatal carrier screening for cystic fibrosis. Obstet Gynecol 1994;84:903-12.","journal-title":"Obstet Gynecol"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000472268","article-title":"Heterozygote screening for cystic fibrosis","volume":"3","author":"Brock, D.J.H.","year":"1995","unstructured":"Brock DJH. Heterozygote screening for cystic fibrosis. EurJ Hum Genet 1995;3:2-13.","journal-title":"EurJ Hum Genet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jcu.1870120109","article-title":"Prenatal diagnosis of cystic meconium peritonitis","volume":"12","author":"Schwimer, SR, Vanley; GT, Reinke; R.T.","year":"1984","unstructured":"Schwimer SR, Vanley GT, Reinke RT. Prenatal diagnosis of cystic meconium peritonitis. Jf Clin Ultrasound 1984;12: 37-9.","journal-title":"Jf Clin Ultrasound"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg.35.8.657","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:22:25Z","timestamp":1760728945000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg.35.8.657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":25,"journal-issue":{"issue":"8","published-online":{"date-parts":[[1998,8,1]]},"published-print":{"date-parts":[[1998,8]]}},"alternative-id":["10.1136\/jmg.35.8.657"],"URL":"https:\/\/doi.org\/10.1136\/jmg.35.8.657","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"type":"print","value":"0022-2593"},{"type":"electronic","value":"1468-6244"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}